⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALDX News
Aldeyra Therapeutics, Inc.
Pomerantz LLP Shares Class Action Details With Shareholders in Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky
globenewswire.com
ALDX
Pomerantz LLP Reminds Shareholders with Losses on their Investment in Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
ALDX Stockholders Have Opportunity to Lead Aldeyra Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
ALDX
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
prnewswire.com
ALDX
Pomerantz LLP Shares Class Action Details With Investors in Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
ALDX
Pomerantz LLP Reminds Investors: Securities Lawsuit Has Been Filed Against Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX
accessnewswire.com
ALDX
ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ALDX